Zhongguo Zhong Xi Yi Jie He Za Zhi
December 2007
Objective: To evaluate the therapeutic efficacy and adverse reaction of Aidi Injection (ADI) combined with FOLFOX4 regimen for treatment of patients with advanced colorectal cancer, and controlled with those of FOLFOX4 regimen alone.
Methods: One hundred and seventeen patients were randomized into two groups. All received FOLFOX4 regimen, i.